Drug Type Small molecule drug |
Synonyms Cefminox, Cefminox Sodium, Cefminox sodium hydrate (JP17) + [7] |
Target |
Action inhibitors |
Mechanism PBPs inhibitors(Bacterial penicillin-binding protein inhibitors), Cell wall inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (30 Jun 1987), |
Regulation- |
Molecular FormulaC16H35N7NaO14S3 |
InChIKeyRHAMUDWZLLKZNK-CVQRGOFGSA-N |
CAS Registry1351813-81-4 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D01909 | Cefminox Sodium Hydrate |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Acute Bronchitis | Japan | 30 Jun 1987 | |
| Adnexal Diseases | Japan | 30 Jun 1987 | |
| Bacterial Infections | Japan | 30 Jun 1987 | |
| Cholecystitis | Japan | 30 Jun 1987 | |
| Cystitis | Japan | 30 Jun 1987 | |
| Hemorrhagic Septicemia | Japan | 30 Jun 1987 | |
| Intrauterine infection | Japan | 30 Jun 1987 | |
| Lung Abscess | Japan | 30 Jun 1987 | |
| Peritonitis | Japan | 30 Jun 1987 | |
| Pneumonia | Japan | 30 Jun 1987 | |
| Pyelonephritis | Japan | 30 Jun 1987 | |
| respiratory tract; infection, chronic | Japan | 30 Jun 1987 | |
| Tonsillitis | Japan | 30 Jun 1987 |





